FDA Rejects Novel Agent for Chemo-induced Neutropenia FDA Rejects Novel Agent for Chemo-induced Neutropenia

The agency said that more clinical data is needed for the novel agent plinabulin for use in the prevention of chemotherapy-induced neutropenia.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news